Semaglutide has an FDA-approved dosing structure with graduated titration. This article covers the label-level dose range, administration format, and titration concept — clinical decisions belong with a qualified healthcare provider.

Wegovy (semaglutide) and Ozempic (semaglutide) are compared across mechanism, FDA-approved indications, evidence base, side effects, cost, and the pathway-level genetic variants — including FTO, GLP1R, and MC4R — that apply regardless of which compound is prescribed.

Retatrutide has an FDA-approved dosing structure with graduated titration. This article covers the label-level dose range, administration format, and titration concept — clinical decisions belong with a qualified healthcare provider.

GLP-1 — glucagon-like peptide-1 — is an incretin hormone. The GLP-1 receptor agonist drug class mimics it pharmacologically. This article covers GLP-1 hormone biology, how the drug class works, what's FDA-approved as of April 2026, and the GLP-1 pathway genetics including GLP1R, FTO, and MC4R.

Trulicity (dulaglutide) has an FDA-approved dosing structure with graduated titration. This article covers the label-level dose range, administration format, and titration concept — clinical decisions belong with a qualified healthcare provider.

Ozempic (semaglutide) and Wegovy (semaglutide) are compared across mechanism, FDA-approved indications, evidence base, side effects, cost, and the pathway-level genetic variants — including FTO, GLP1R, and MC4R — that apply regardless of which compound is prescribed.

Semaglutide oral availability, FDA-approved oral GLP-1 options as of April 2026, how oral GLP-1 absorption works, cost, and the PlexusDx Semaglutide Oral and Tirzepatide Oral protocols inside the Weight Management Protocols collection.

Microdose GLP-1 protocols use lower-than-standard doses of GLP-1 receptor agonists titrated by a clinician for better tolerability. This article covers what microdose means, the rationale, and the PlexusDx Microdose GLP-1 protocol inside the Weight Management Protocols collection.

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers manufacturer savings programs, insurance coverage notes, compounded alternatives, and the PlexusDx Weight Management Protocols collection — all as of April 2026.

Zepbound (tirzepatide) has an FDA-approved dosing structure with graduated titration. This article covers the label-level dose range, administration format, and titration concept — clinical decisions belong with a qualified healthcare provider.

Ozempic (semaglutide) has an FDA-approved dosing structure with graduated titration. This article covers the label-level dose range, administration format, and titration concept — clinical decisions belong with a qualified healthcare provider.

Zepbound list price is approximately $1,059 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers manufacturer savings programs, insurance coverage notes, compounded alternatives, and the PlexusDx Weight Management Protocols collection — all as of April 2026.

Ozempic list price is approximately $968–$1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers manufacturer savings programs, insurance coverage notes, compounded alternatives, and the PlexusDx Weight Management Protocols collection — all as of April 2026.

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers manufacturer savings programs, insurance coverage notes, compounded alternatives, and the PlexusDx Weight Management Protocols collection — all as of April 2026.

Ozempic list price is approximately $968–$1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers manufacturer savings programs, insurance coverage notes, compounded alternatives, and the PlexusDx Weight Management Protocols collection — all as of April 2026.

Ozempic Vulva explained — what is being described, why it can happen, what the published trial evidence shows, and the GLP-1 pathway genetic context. Treated with clinical dignity. Individual results vary.

GLP-1 — glucagon-like peptide-1 — is an incretin hormone. The GLP-1 receptor agonist drug class mimics it pharmacologically. This article covers GLP-1 hormone biology, how the drug class works, what's FDA-approved as of April 2026, and the GLP-1 pathway genetics including GLP1R, FTO, and MC4R.

GLP-1 — glucagon-like peptide-1 — is an incretin hormone. The GLP-1 receptor agonist drug class mimics it pharmacologically. This article covers GLP-1 hormone biology, how the drug class works, what's FDA-approved as of April 2026, and the GLP-1 pathway genetics including GLP1R, FTO, and MC4R.

GLP-1 receptor agonist medications oral availability, FDA-approved oral GLP-1 options as of April 2026, how oral GLP-1 absorption works, cost, and the PlexusDx Semaglutide Oral and Tirzepatide Oral protocols inside the Weight Management Protocols collection.

Wegovy oral availability, FDA-approved oral GLP-1 options as of April 2026, how oral GLP-1 absorption works, cost, and the PlexusDx Semaglutide Oral and Tirzepatide Oral protocols inside the Weight Management Protocols collection.

Mounjaro (tirzepatide, Eli Lilly) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Ozempic (semaglutide, Novo Nordisk) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Wegovy (semaglutide, Novo Nordisk) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

GLP-1 receptor agonist medications oral availability, FDA-approved oral GLP-1 options as of April 2026, how oral GLP-1 absorption works, cost, and the PlexusDx Semaglutide Oral and Tirzepatide Oral protocols inside the Weight Management Protocols collection.

Wegovy oral availability, FDA-approved oral GLP-1 options as of April 2026, how oral GLP-1 absorption works, cost, and the PlexusDx Semaglutide Oral and Tirzepatide Oral protocols inside the Weight Management Protocols collection.

Ozempic Face explained — what is being described, why it can happen, what the published trial evidence shows, and the GLP-1 pathway genetic context. Treated with clinical dignity. Individual results vary.

Genetic testing doesn't treat sexual dysfunction — it maps the biological terrain that every treatment decision operates within. The Precision Peptide Genetic Test delivers 6 Sexual Health insights across 14 pathways, 49 peptides, and 150+ genetic insights, giving providers the upstream biological context that bloodwork alone cannot supply — and changing the clinical conversation before any protocol begins.

In the Precision Peptide Genetic Test, the Sexual Health pathway delivers 6 insights across the genes governing central arousal, vascular sexual response, desire, bonding, and circadian sexual timing. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 variants map sexual biology as a connected system — not a checklist of isolated traits.

PDE5 pathway support compounds work differently for different men because the upstream signal they amplify — eNOS-derived nitric oxide — is genetically variable. NOS3 genotype sets the vascular floor. The Precision Peptide Genetic Test maps this and other pathway variables across 14 pathways, 49 peptides, and 150+ genetic insights, explaining the response variability that dosing alone cannot.

Libido has a genetic architecture — DRD2 receptor density, OXTR bonding sensitivity, MTNR1B circadian timing, and MC4R central arousal signaling all shape sexual desire at the neurochemical level. The Precision Peptide Genetic Test maps these variables as part of 14 pathways, 49 peptides, and 150+ genetic insights, explaining the biology of desire that testosterone panels miss.